Protein sparing modified fasts have been studied in adults, but little data exist for adolescents. This study was designed to evaluate a high protein liquid (HPL) diet tifa fast-7oR, Delmark) in excessively overweight adolescents (>175% IBW). 7 subjects ages 14-18 were studied for 5 weeks as inpatients, and 4 for another 4-6 months as outpatients. After 1 week on a 1000 calorie mixed diet they were given HPL diet in amounts providing 7callkglIBW and protein l.5gm/kg/1~w. All patients tolerated the diet well and lost considerable amounts of weight. Frequent 24 hour ECG monitoring showed no significant abnormalities. Resting metabolic rate decreased 20% over the first 5 weeks and a further 5-10% over the next months. Nitrogen balance during the first 5 weeks was +1.65+2.45gN/d (SD). Lean body mass (K-40 counting) decreased during the first month and then levelled off, whereas body fat continued to decrease.
Initial month 7 -3.321.5 -3.6t2.7 48 52 Per mon thereafter 4 -.48+.27 -3.8t1.0 11 89 These data suggest that the high protein low calorie diet as used in this study spares lean body mass and maintains nitrogen balance in the excessively obese adolescent. Recent studies in patients with repair of esophageal atresia and tracheoesophageal fistula show a high incidence of significant abnormalities of esophageal function. We have studied 20 patients operated on over the past 12 years. Ages ranged from 4 months to 12 years (av. 5.9 yrs). Studies included history, esophageal manometry, pH probe acid reflux test (Tuttle) and barium esophagram.
The only symptom present was occasional dysphagia for solid foods in 5 patients. Three had had a coin removed and 4 had required dilatation. Seven patients had a history of pneumonia.
Only 1 patient had a lower esophageal sphincter pressure less than 12mm Hg. In 5, peristalsis was abnormal by manometry and in 5 by esophagram. However, only 1 patient was in both groups. Minimal reflux was seen in 5 patients by esophagram and in 6 by Tuttle test. Only 1 patient was in both groups. As the patients became older, symptoms decreased.
This study reveals fewer severe abnormalities than previously described. Minimal reflux seems to occur frequently without sequellae and most problems in our patients were related to esophageal narrowing requiring dilatation. Injection of cortisone is known to induce sucrase activity precociously in suckling rodents. A recent report (Develop. Biol. 69:661) indicated a similar effect of insulin in mice. To study the mechanism of this insulin induction, we have attempted to reproduce the experiments reported, using Swiss ICR mice and injecting insulin daily (12.5 mU/g BW/day, s.c.) starting on day 8 and sacrificing 24 and 72 hours later. No precocious induction of sucrase was observed, but interesting effect on lactase was seen. These data as well as data on littermates treated with cortisone acetate (25 ug/g day) are summarized below [only values for midjejunum are given, similar results were observed in proximal jejunum and ileum; lactase activity (umoles/60 min) is given per mg of protein (SA), or per segment (TA); mean t SEM (N). Excessive protein loss through the gastrointestinal tract is difficult to diagnose and quantitate because of the nonavailability of radiolabelled proteins and the disadvantages of their administration to children. Alpha-1-antitrypsin (a1AT) is an endogenous protein which is resistant to proteolytic digestion in the intestine, not found in the diet and as suggested by others should reflect plasma protein loss into the GI tract. We investigated its usefulness by measuring the fecal alAT concentration in 24 patients with no malabsorption, 12 patients with cystic fibrosis (high fecal nitrogen), 10 patients with fat malabsorption only and 3 patients with protein-losing enteropathies. Stool aliquots were taken from 48-72 hour homogenized stool collections which had been evaluated for fecal fat. Five lambda samples were directly applied to and quantitated by radial immunodiffusion plates specific for anti-human alAT (Boehringer-Mannheim) . "Normal" daily alAT loss expressed in mg/kg body wt/day was 1.70 t 1.32 with similar values for cystic fibrosis (0.99 t 0.68, p>O.O5) and isolated fat malabsorption (1.51 2 1.03, p>0,05). The alAT loss for the 3 patients with protein-losing enteropathies (two with lymphangectasia, one undiagnosed) varied from 4. Children's Hospital, Little Rcck, Arkansas. Basal acid output (EAO) and pentagastrin (6 ug/kg SC) stinulated mutima1 acid output (MAO) were masured in 42 normal (NL) children (age range 2-144 m ; X = 19.4 m). Similar measurements were made in 16 patients with PUD (age range 3-216 m; R = 96.6 m) including 7 waluated b t h before and after 6 w e k s of therapy. PA0 and MA0 w r e calculated by conventional technique with hydrogen ion concentration determined by titration to pH 7.0.
The PA0 and MA0 in the NL children were (R t SEM) 0.17 k 0.22 & kg/hr and 1.38 t 0.61 mq/kg/hr respectively. , Although older heavier children produced m r e total acid than younger smaller ones, on a per kg basis no correlation was found between acid output (PAO/MAO) and increasing weight. Neither was there a correlation found between acid output (EAO/%lAO; nq/kg/hr) and either height, age or sex. There was no significant difference bebeen either the BAO (0.08 k 0.02 mq/kg/hr) or the (0.90 t 0.14 neq/kg/hr) in the PUD patients and the values obtained in NL children (p > 0.05). There was also no significant difference between the groups for either BAO or MAO when cgnparisons w2re made on a -2/hr basis. Pre and ~o s t trea-t EAO and MA0 values in PUD patients were not statistically different (p > 0.5). In conclusion: 1) Since neither the BAO or the MA0 in children correlated with weight, height, age or sex, gastric acid secretory data should be interpreted on a n-eq/kg/hr basis. 2) Gastric acid hypersecretion was not found in children with PUD either before or after treatment. 
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